Biopharming of Lactoferrin: Current Strategies and Future Prospects
Pharmaceutics · 07.08.2025 · 17 (8) · 1023
DOI: 10.3390/pharmaceutics17081023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 07.08.2025. Verfasst von Rajaravindra Konadaka Sri und 8 weiteren Autor:innen. Beteiligte Einrichtung: ICAR-Directorate of Poultry Research, Hyderabad 500030, India. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Department of Biotechnology (DBT), Government of India.
Abstract (Originalsprache)
Lactoferrin (LF) is an 80 kDa iron-binding glycoprotein primarily found in milk, saliva, tears, and nasal secretions. LF is well known for its antibacterial and immunomodulatory effects. However, the extraction of LF from milk is inadequate for large-scale therapeutic applications, presenting a challenge for economic mass production. Recombinant protein expression systems offer a solution to overcome this challenge and efficient production of LF. This review discusses recent progress in the translational research of LF gene transfer and biopharming, focusing on different expression systems such as bacteria, yeast, filamentous fungi, transgenic crops, and animals as well as purification methods. The optimization of expression yields, prospects for genetic engineering, and biotechnology to enhance LF production for biomedical applications are emphasized. This review systematically sourced the literature from 1987 to 2025 from leading scientific databases, including PubMed, Scopus, Web of Science, and Google Scholar. Despite ongoing debates, progress in this field indicates a viable path towards the effective use of LF in therapeutic settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ICAR-Directorate of Poultry Research, Hyderabad 500030, India.
- ICAR-National Research Centre on Equines, Hisar 125001, India.
ORCID-Profile: Parthasarathi Balasamudram Chandrasekhar, Thejasri Jakkoju, Rajith Reddy Bheemreddy, Tarun Kumar Bhattacharya
Förderung
- Department of Biotechnology
- Department of Biotechnology (DBT), Government of India
Zitieren
APA
Konadaka Sri, R., Balasamudram Chandrasekhar, P., Sirisilla, A., Mohammed, Q. K. Q., Jakkoju, T., Bheemreddy, R. R., Bhattacharya, T. K., Ullengala, R., & Chatterjee, R. N. (2025). Biopharming of Lactoferrin: Current Strategies and Future Prospects. Pharmaceutics, 17(8), 1023. https://doi.org/10.3390/pharmaceutics17081023
Vancouver
Konadaka Sri R, Balasamudram Chandrasekhar P, Sirisilla A, Mohammed QKQ, Jakkoju T, Bheemreddy RR, et al. Biopharming of Lactoferrin: Current Strategies and Future Prospects. Pharmaceutics. 2025;17(8):1023. doi:10.3390/pharmaceutics17081023
BibTeX
@article{KonadakaSri2025,
author = {Konadaka Sri, Rajaravindra and Balasamudram Chandrasekhar, Parthasarathi and Sirisilla, Architha and Mohammed, Qudrathulla Khan Quadri and Jakkoju, Thejasri and Bheemreddy, Rajith Reddy and Bhattacharya, Tarun Kumar and Ullengala, Rajkumar and Chatterjee, Rudra Nath},
title = {Biopharming of Lactoferrin: Current Strategies and Future Prospects},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {8},
pages = {1023},
doi = {10.3390/pharmaceutics17081023}
}
EUVIMED